Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
User

Lindsell Train TMO trades

Michael Lindsell, Nick Train

Lindsell Train Thermo Fisher Scientific Inc stake

total: 40

Trades details

Total transactions:
7
New positions:
1
Added:
2
Reduced:
4
Held since:
2024 Q4
Held for:
7 quarters
Latest activity:
2026 Q2
According to 2026 Q2 report, Lindsell Train holds 514,512 Thermo Fisher Scientific Inc (TMO) shares with a market value of roughly $257.96M accounting for 9.81% of the overall portfolio. To date, the estimated cost basis is nearly $471.1 for "buy" trades and estimated average "sell" price is $526.89. Lindsell Train first purchased TMO in 2024 Q4, initially acquiring 407,240 shares. Since the initial investment in Thermo Fisher Scientific Inc (TMO), Lindsell Train has made 6 more transactions.

How many TMO shares does Lindsell Train currently hold?

According to 2026 Q2 report, Lindsell Train holds 514,512 shares of Thermo Fisher Scientific Inc (TMO), valued at around $257.96M.

When did Lindsell Train buy Thermo Fisher Scientific Inc (TMO)?

Lindsell Train first invested in Thermo Fisher Scientific Inc (TMO) in 2024 Q4 at the reported quarter-end price of $520.23 per share.

What's the cost basis of Lindsell Train's TMO stake?

The estimated cost basis for Thermo Fisher Scientific Inc (TMO) stake is around $471.10 per share. This represents their average reported price* across all buy transactions

Estimated cost basis*

Weighted AVG buy price:
$471.10
Weighted AVG sell price:
$526.88

Lindsell Train's historical trades in Thermo Fisher Scientific Inc

7 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q2
9.81%
514,512
$501.36
$257,955,736
-16.64% (-102,699)
-1.64%
2026 Q1
9.67%
617,211
$491.53
$303,377,723
-10.48% (-72,292)
-0.9%
2025 Q4
10.13%
689,503
$579.45
$399,532,513
-15.66% (-128,026)
-1.82%
2025 Q3
9.73%
817,529
$485.02
$396,517,916
-4.34% (-37,083)
-0.42%
2025 Q2
8.17%
854,612
$405.46
$346,510,982
+67.97% (+345,822)
+3.3%
2025 Q1
7.01%
508,790
$497.60
$253,173,904
+24.94% (+101,550)
+1.4%
2024 Q4
5.30%
407,240
$520.23
$211,858,465
new
+5.3%
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.